OppenheimerFunds’s Amicus Therapeutics FOLD Stock Holding History

OppenheimerFunds’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$8.84M	Buy	+650,240	New	+$7.94M	0.01%	685

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds's FOLD Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Amicus Therapeutics (FOLD) in Q1 2019: 650,240 shares worth $8.84M. The stake represents 0.01% of the portfolio and ranks #685 among its holdings.

205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

OppenheimerFunds held 650,240 shares of Amicus Therapeutics worth $8.84M as of Q1 2019.
Amicus Therapeutics was a new OppenheimerFunds position in Q1 2019.
Amicus Therapeutics made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #685 holding.
205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.